Combating Counterfeit Drugs in China Chen Xu Ph.D. Director of Division of Drug Supervision and Inspection Department of Drug Market.

Slides:



Advertisements
Similar presentations
China IP Criminal Protection
Advertisements

Government of the Republic of Serbia Ministry of Labor and Social Policy GENERAL AND SPECIAL PROTOCOL ON CHILD PROTECTION FROM ABUSE AND NEGLECT.
BRIEF INTRODUCTION TO RAPEX-CHINA
Environmental Protection Agency Montenegro. Competent Authority Since November 2006, The competent authority for environmental issues was the Ministry.
EU-China Cooperation in Tobacco Sector EU-China Cooperation in Tobacco Sector.
Combating counterfeit medicines in Vietnam. Issues Definitions of counterfeit medicines and concerned legal documents National coordination Number of.
Country Presentation Myanmar
International Medical Products Anti-CounterfeitingTaskforce INSPECTOR OF DRUGS NATIONAL DRUG AUTHORITY- UGANDA.
IMPACT REGIONAL CONFERENCE ON COMBATING COUNTERFEIT MEDICAL PRODUCT: 9-10 NOVEMBER 2009: KEMPTON PARK,SOUTH AFRICA: BY DETECTIVE INSPECTOR NAMIBIA.
International Medical Products Anti-CounterfeitingTaskforce.
WHO Good Distribution Practices for Pharmaceutical Products
1 Florida Department of Corrections Presentations to the Senate Committee on Criminal and Civil Justice Appropriations December 13, 2007.
YIN Jie China National Cleaner Production Center CP Promotion Law in China
Biopharmaceutical Quality
BACKGROUND: The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Government of the People's Republic of Bangladesh,
Nuclear and Radiation Safety Center, China Regulatory requirements on management of radioactive material safe transport in China Reporter: Xu Chunyan Division.
Ministry of Agriculture and Rural Development CONTROL OF PLANT PROTECTION PRODUCTS ON MARKET IN ROMANIA Nicoleta Predescu, PhD., Chem. Eng. Central Laboratory.
GMP Document and Record Retention
Transparency of China’s International Biddings of Electromechanical Products and the Complaints Handling Mechanism National Office for Import and Export.
Department of Transportation Support Services Branch ODOT Procurement Office Intergovernmental Agreements 455 Airport Rd. SE, Bldg K Salem, OR
Eurojust The European Union’s Judicial Cooperation Unit.
Regulatory Body MODIFIED Day 8 – Lecture 3.
Prof. GAO yongfu Shanghai University of International Business and Economics May 16-17, 2013.
China Compulsory Product Certification System- CCC Mark.
10th Baltic Electronic Communications & Postal Services Regulators’ Meeting Latvia, 29 August 2013 Postal market supervision Kristina Masiulytė Acting.
Audit of Public Procurement
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency 1 Module 13 GMP Workshop.
New Progress in China’s Administrative Protection on the Exclusive Right to Use a Registered Trademark Ren Gang, Director of Legal Affairs Division,
LEGAL FRAMEWORK & REGULATORY SYSTEM f or introduction of NPP into Vietnam Le Chi Dung (VARANS, Vietnam) Vienna, December 2008.
Implementation of “ APEC Anti-corruption Code of Conduct for Business ” by Chinese State-Owned Enterprises (SOEs) - Mr. SHAO CHUNBAO - CHINA TELECOM -
Chinese Foreign Trade Law Jiaxiang Hu Professor of Law, School of Law, SJTU.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENSHIP JUSTICE
Module N° 8 – SSP implementation plan. SSP – A structured approach Module 2 Basic safety management concepts Module 2 Basic safety management concepts.
1 Examples of subregional collaboration: the experience of Operation Mamba I & II in East African Community (EAC) The case of TANZANIA IMPACT.
A.ABDULLAEV, Director of the Public Fund for Support and Development of Print Media and Information Agencies of Uzbekistan.
June, 2013 MINISTRY OF PUBLIC ADMINISTRATION 1 MÉXICO.
Europol Police Directorate International Operational Police Cooperation Department INTERPOL EUROPOL SELEC THURSDAY 12 DECEMBER 2013.
The 3rd package for the internal energy market Key proposals EUROPEAN COMMISSION Heinz Hilbrecht Directorate C - Security of supply and energy markets.
POLICE OF THE CZECH REPUBLIC NATIONAL DRUG HEADQUARTERS CRIMINAL POLICE AND INVESTIGATION SERVICE Beograd,
European Commission Rita L’ABBATE Legal aspects linked to internal market DG Enterprise and Industry MARKET SURVEILLANCE COMMUNITY FRAMEWORK UNECE “MARS”
NEGOTIATING TRADE FACILITATION Kennedy Mbekeani UNDP, RSC.
1 Accounts Chamber of the Russian Federation. The Accounts Chamber of the Russian Federation 2 PreventiveRepressive.
Office of the President Office of the Chief of Staff Secretariat of Environment and Sustainable Development.
IAEA International Atomic Energy Agency Senior Regulators’ Meeting 2013 Radiation Safety Infrastructure in Non- Nuclear Countries Pil Soo Hahn Director.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Regulatory Authority.
IAEA International Atomic Energy Agency School of Drafting Regulations – November 2014 Government and Regulatory Body Functions and Responsibilities IAEA.
PUBLIC PROCUREMENT SYSTEM IN TAJIKISTAN RAVSHAN KARIMOV AGENCY FOR PUBLIC PROCUREMENT UNDER THE GOVERNMENT OF THE REPUBLIC OF TAJIKISTAN.
BULGARIA STATE AGENCY FOR METROLOGY AND TECHNICAL SURVEILLANCE BULGARIA 2003.
Directorate General for Enterprise and Industry European Commission The New Legislative Framework - Market Surveillance UNECE “MARS” Group meeting Bratislava,
Human Embryos and Gene-editing Research and regulation in China Prof. Zhihong Xu, Peking University & Chinese Academy of Sciences.
The New Legislative Framework
MINISTRY OF FINANCE Counsellor, docent, Dr Tuomas Pöysti1 The Constitutionalisation and Evolution of Penal Law and Control Policy in the European.
Product Recall Laws in China Xiangwen Liu Partner King & Wood PRC Lawyers.
IPR Enforcement in the United Kingdom Kenny Wright Danish Patent and Trademark Office.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.
By Prof. Dr. PI Yong Wuhan University of China New China Criminal Legislation against Cybercrime in the Common Internet.
European Commission The New Legislative Framework Jacques McMillan Head of Unit Directorate General for Enterprise and Industry Regulatory approach for.
The Public Tendering and Bidding (招投标) Law of the People's Republic of China Effective since January 1, 2000.
TAIEX INTERNAL MARKET WEEK IN BUDAPEST November 2004 Co-operation of Customs Administrations Presentation by: Sandro Le Noci – Italian Customs.
Director, Environmental Assessment & Control Directorate
The activities of the state tax authorities
The 3rd package for the internal energy market
PRESENTATION OF MONTENEGRO
Establishing the Infrastructure for Radiation Safety Preparatory Actions and Initial Regulatory Activities.
Director, Environmental Assessment & Control Directorate
Ministry of Social Security and Labour
Alcohol and Drug Policy Changes in Russia – 2019
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
ODS licensing and annual quota system relationship and differences
Presentation transcript:

Combating Counterfeit Drugs in China Chen Xu Ph.D. Director of Division of Drug Supervision and Inspection Department of Drug Market Compliance State Food and Drug Administration People s Republic of China Department of Drug Market Compliance State Food and Drug Administration People s Republic of China

2 What legislation is currently used for SFDA to combating counterfeit drug? China had first Drug Administration Law in 1985,which contained special articles for combating counterfeit drugs Drug Administration Law was revised in 2001, provided more specific Articles for combating counterfeit drugs. Regulations for Implementation of Drug Administration Law promulgated in 2002, and also contained special articles for combating counterfeit drugs. The State Council special regulation for strengthens food and drug security Surveillance was published and implemented on July 25, 2007,which contained special articles for combating counterfeit drug too.

3 Article 48(Drug law) Production (including dispensing, the same below) and distribution of counterfeit drugs are prohibited. N ational definitions of counterfeit drug are followings: A drug is a counterfeit drug in any of the following cases: (1) the ingredients in the drug are different from those specified by the national drug standards; or (2) a non-drug substance is simulated as a drug or one drug is simulated as another. A drug shall be treated as a counterfeit drug in any of the following cases: (1) its use is prohibited by the regulations of the drug regulatory department under the State Council; (2) it is produced or imported without approval, or marketed without being tested, as required by this Law; (3)it is deteriorated; (4) it is contaminated; (5) it is produced by using drug substances without approval number as required by this Law; or (6) the indications or functions indicated are beyond the specified scope.

4 Article 49(Drug law) Production and distribution of substandard drugs are prohibited. N ational definitions of substandard drug are followings: A drug with content not up to the national drug standards is a substandard drug. A drug shall be treated as a substandard drug in any of the following cases; (1) the date of expiry is not indicated or is altered; (2) the batch number is not indicated or is altered; (3) it is beyond the date of expiry; (4) no approval is obtained for the immediate packaging material or container; (5) colorants, preservatives, spices, flavorings or other excipients are added without authorization; or (6) other cases where the drug standard are not conformed.

5 What are gaps in current legislation and how to meet gaps? In China, SFDA is responsible for administrative punishment on counterfeit drug including to investigate & penalize illegal activities of manufacturing, selling, using counterfeit drugs). But SFDA is not rresponsible for criminal punishment on counterfeiting. In China, SFDA is responsible for administrative punishment on counterfeit drug including to investigate & penalize illegal activities of manufacturing, selling, using counterfeit drugs). But SFDA is not rresponsible for criminal punishment on counterfeiting. In order to meet the gaps, SFDA cooperates with other government bodies. In order to meet the gaps, SFDA cooperates with other government bodies. –working with the Public Security Ministry for criminal punishment for manufacturing & selling counterfeit drugs, –working with the Public Security Ministry for criminal punishment for manufacturing & selling counterfeit drugs, –working with Postal Office for eliminating, closing of mail orders & mail boxes of counterfeit drugs. –working with Postal Office for eliminating, closing of mail orders & mail boxes of counterfeit drugs. –working with the Customs Office to control of smuggling counterfeit drug. –working with the Customs Office to control of smuggling counterfeit drug.

6 What is being done to fill the gaps? Now we, SFDA has established regular and long term cooperation mechanisms with the above Depts. We have established fixed office, fixed meeting timetable, fixed hot line, and so on. Now we, SFDA has established regular and long term cooperation mechanisms with the above Depts. We have established fixed office, fixed meeting timetable, fixed hot line, and so on. For example, during March 25, to September 25,2003 SFDA carried out jointly by the Ministry of Public Security to combat the production and selling of counterfeit medicines in a nationwide scale. SFDA and the Ministry of Public Security had set up a special action leading group in charge of this special operation command coordination. The local DRA and public security also set up specialized agencies, responsible for organization and leadership work, and to identify hand, is responsible for the coordination of special action links. This special operation, the goal is to destroy key areas of production, selling of counterfeit medicines, and sales networks, and prosecute the illegal production and sale of counterfeit criminals, and to effectively check the manufacture and sale of counterfeit medicines. Establish a perfect anti-counterfeit long-term cooperation mechanism to purify medicine market order, and ensure the safety of the masses medication. For example, during March 25, to September 25,2003 SFDA carried out jointly by the Ministry of Public Security to combat the production and selling of counterfeit medicines in a nationwide scale. SFDA and the Ministry of Public Security had set up a special action leading group in charge of this special operation command coordination. The local DRA and public security also set up specialized agencies, responsible for organization and leadership work, and to identify hand, is responsible for the coordination of special action links. This special operation, the goal is to destroy key areas of production, selling of counterfeit medicines, and sales networks, and prosecute the illegal production and sale of counterfeit criminals, and to effectively check the manufacture and sale of counterfeit medicines. Establish a perfect anti-counterfeit long-term cooperation mechanism to purify medicine market order, and ensure the safety of the masses medication.

7 If the case of counterfeit drugs accords with the demands of criminal punishment, DRA must promptly transfer it to the public security bodies according to the stipulation, positively coordinates the judicial bodies to develop pursues the punishment work, including collects and the production of evidence. Has a suspect clue of criminal case, SFDA must propose the public security bodies to involve ahead of time, the coordination investigation, prevented and avoids the criminal suspect as far as possible escaping, already escaped must assist the public security bodies to seize as soon as possible brings to justice. If the case of counterfeit drugs accords with the demands of criminal punishment, DRA must promptly transfer it to the public security bodies according to the stipulation, positively coordinates the judicial bodies to develop pursues the punishment work, including collects and the production of evidence. Has a suspect clue of criminal case, SFDA must propose the public security bodies to involve ahead of time, the coordination investigation, prevented and avoids the criminal suspect as far as possible escaping, already escaped must assist the public security bodies to seize as soon as possible brings to justice. The conditions for DRA to transfer counterfeit case to the public security body: The conditions for DRA to transfer counterfeit case to the public security body: (1) Individual illegal sale counterfeit drug amount 50,000 Yuan (RMB) above, or illegal obtained amount in 10,000 Yuan (RMB) above; (2) Unit illegal sale counterfeit drug amount 500,000 Yuan (RMB) above, or illegal obtained amount in 100,000 Yuan (RMB) above; (3) The production and sale of counterfeit drug, also sufficiently causes the human body serious harm, may directly carry on processing by the public security department according to the criminal law, not above amount limit. What is being done to fill the gaps?

8 What are proposal for actions of IMPACT? (1) Measures to be taken: (a) Signing work cooperation document, making corresponding working routine. (b) Establishing special department, the personnel are responsible to coordinate the routine duties. (c) Establishing the platform of information exchange, is prompt, accurately the sharp related counterfeit information. (2) WHO should do it? (a) The coordination, management of IMPACT throughout member countries. (3)Transsmitting information to related country. (b)Providing the essential funds, and technical supports to the various countries.

9 What are proposal for actions of IMPACT? (3)Critical factors to ensure success (a) The various countries' work develops and cooperates, WHO must establish in the equal and in the cooperation foundation, does not interfere the various countries' investigation work. (b) Information exchange provided by IMPACT system must be traceable according to the evidence which may look up. (c) Funds safeguard. (4)Realistic timeframe After completion of above work, all participates of IMPACT can be in motion together. (5) Cost estimate Needs 4 million US dollars funds budget every year in China.